Tsuruha Holdings Inc.

3391.T
Pharmaceutical Retailers
2026/07/23 Updated
Market Cap: $6.6B (¥1.1T)
Stock Price: $14.57 (¥2,377)
Exchange Rate: 1 USD = ¥163.13

【Tsuruha Holdings】Q1 2027 Earnings Results|Sales ¥636.8 billion (+133.7% YoY)

Tsuruha Holdings achieved sales of ¥636.8 billion (YoY +133.7%) and net income of ¥134.7 billion (21.3% increase) in Q1 2027, promoting store expansion and synergy effects based on its medium-term management plan.

Importance:
Page Updated: July 14, 2026
IR Disclosure Date: July 14, 2026

Key Figures

  • Sales: ¥636.8 billion (+133.7% YoY)
  • Net Income: ¥134.7 billion (+21.3% YoY)
  • Number of Stores: 5,665 (at the end of Q1)

AI要約

Performance Overview

In Q1 2027, Tsuruha Holdings recorded sales of ¥636.8 billion (YoY +133.7%), operating income of ¥24.2 billion (YoY +94.3%), and net income of ¥134.7 billion (YoY +21.3%). Based on its medium-term management plan, the company has been promoting store openings, renovations, and system integrations, resulting in increased domestic and international store count. Contributing factors include pharmacy integrations and expansion into the food category, which have helped enlarge market share.

Future Outlook and Impact on Shareholders

Under the medium-term management plan, Tsuruha Holdings will continue strengthening the competitiveness of existing stores nationwide and opening new stores. Through synergy creation and store renovations, the company aims to expand sales and profits. Shareholders can expect sustained dividends and growth prospects driven by ongoing store expansion. The company's financial position remains solid, and proactive business development is planned to continue.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Tsuruha Holdings Inc.

Company overview · Stock price · Financial data · All IR

View company page →